[APDN] Applied DNA Sciences Inc


Type of security: Stock

Sector: Consumer Services

Industry: Other Consumer Services

Market Capitalization: 77.3 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 2 Change: -0.05 (-2.44%)
Ext. hours: Change: 0 (0%)

chart APDN

Refresh chart

Strongest Trends Summary For APDN

APDN is in the long-term down -90% below S&P in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Applied DNA Sciences, Inc. provides botanical-DNA based anti-counterfeiting and product authentication solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, and Asia. The company offers SigNature DNA markers for embedment into a range of media, such as inks, dyes, textile treatments, thermal ribbon thread, laminates, glues, threads, varnishes, adhesives, and metal coatings; SigNature T botanical DNA markers for use in brand protection efforts and raw material source compliance programs; and SmartDNA, a patented security system for stores, warehouses, banks, pharmacies, and ATMs, as well as for the protection of valuables. It also provides DNANet tactical DNA products for law enforcement in the form of DNA-marked fixative sprays and liquids; digitalDNA, a DNA-secured form of the quick read code to create customer interface; fiberTyping solution, which is used in DNA verification for manufacturers, retailers, and brand owners to ensure quality, saf

Fundamental Ratios
Shares Outstanding24.08 M EPS-0.53 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 80.62% Sales Growth - Q/Q22.3% P/E-1.89
P/E To EPS Growth P/S18.2 P/BV39.54 Price/Cash Per Share
Price/Free Cash Flow-8.84 ROA-378.83% ROE-702.45% ROI
Current Ratio1.38 Quick Ratio Long Term Debt/Equity Debt Ratio0.85
Gross Margin Operating Margin-259.56% Net Profit Margin-323.45% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.8 M Cash From Investing Activities-230 K Cash From Operating Activities-3.97 M Gross Profit
Net Profit-1.89 M Operating Profit-1.88 M Total Assets3.63 M Total Current Assets2.3 M
Total Current Liabilities1.67 M Total Debt Total Liabilities1.67 M Total Revenue1.52 M
Technical Data
High 52 week2.68 Low 52 week1.11 Last close1.12 Last change-4.27%
RSI16.67 Average true range0.09 Beta0.35 Volume207.81 K
Simple moving average 20 days-17.19% Simple moving average 50 days-13.63% Simple moving average 200 days-20.54%
Performance Data
Performance Week-9.68% Performance Month-24.83% Performance Quart-18.84% Performance Half-25.33%
Performance Year-54.47% Performance Year-to-date-29.56% Volatility daily3.32% Volatility weekly7.43%
Volatility monthly15.24% Volatility yearly52.78% Relative Volume261.52% Average Volume146.41 K
New High New Low


2019-09-05 05:30:00 | Applied DNA Extends Textiles Business to Include Global Down and Feather Supply Chain in Partnership with Industry Leader Navarpluma

2019-08-17 14:18:44 | Edited Transcript of APDN earnings conference call or presentation 13-Aug-19 8:30pm GMT

2019-08-13 16:05:00 | Applied DNA Reports Fiscal Third Quarter 2019 Financial Results

2019-08-12 09:00:00 | Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx

2019-08-08 05:30:00 | LineaRx Acquires Assets and Intellectual Property of Vitatex

2019-08-07 08:30:00 | Applied DNA Signs Master Services Agreement with Schreiner Group to Deliver SigNature® DNA Labels to Protect Pharmaceutical Supply Chains

2019-08-06 05:00:00 | Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET

2019-08-05 09:00:00 | Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement

2019-07-17 13:50:06 | How Much Of Applied DNA Sciences, Inc. NASDAQ:APDN Do Insiders Own?

2019-07-17 11:07:00 | Applied DNA Raises $1.5 Million In Secured Convertible Notes

2019-07-02 09:25:00 | Applied DNA Signs 5-Year Agreement with Iconic Writing Instrument Specialist Montblanc-Simplo GMBH to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients

2019-07-01 12:38:24 | Edited Transcript of APDN earnings conference call or presentation 9-May-19 8:30pm GMT

2019-07-01 09:25:00 | LineaRx Receives Multiple Purchase Orders for Linear DNA for Use in Therapeutic Development

2019-06-26 09:15:00 | LineaRx Ships DNA to Support Therapy Development for Neurodegenerative Diseases

2019-06-24 08:05:00 | TheraCann Adds Blockchain Functionality to ETCH biotrace Platform Powered by Applied DNA 

2019-06-14 08:00:00 | Molecular Tagging of Pharmaceutical Drugs Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal

2019-06-10 08:00:00 | Applied DNA Cannabis Partner TheraCann International Secures Agreement with South Africa’s House of Hemp

2019-06-04 08:00:00 | Applied DNA and Integrated Supply Chain Partners Scale Up to Provide Global Material Traceability for Companies Declaring “2020” Sustainability Goals

2019-05-30 08:00:00 | Applied DNA Closes the Loop on Traceability for Egyptian Pima with Genotyping Assays for Cotton Authentication

2019-05-21 05:30:00 | LineaRx Anticipates Expansion in Diagnostics Market via Follow-on Order and New Linear DNA Amplicons for Additional Assay

2019-05-15 08:04:00 | TheraCann and CannAcubed Enter Collaboration Agreement to Validate Cannabis and Hemp Supply Chain in China

2019-05-10 05:00:00 | Applied DNA to Webcast 2019 Annual Stockholders’ Meeting

2019-05-09 17:40:41 | Applied DNA Sciences: Fiscal 2Q Earnings Snapshot

2019-05-09 16:05:00 | Applied DNA Reports Fiscal Second Quarter 2019 Financial Results

2019-05-08 08:30:00 | A&E to Preview ‘Integrity’ Molecular-Tagged Thread Solution From Applied DNA Sciences at Texprocess

2019-05-02 05:30:00 | Applied DNA’s Molecular Tagging Technology to Ensure Authenticity of Egyptian Cotton

2019-05-02 04:00:00 | Applied DNA Schedules Fiscal 2019 Second Quarter Financial Results Conference Call for Thursday, May 9, 2019 at 4:30 PM ET

2019-04-29 11:44:48 | If You Had Bought Applied DNA Sciences NASDAQ:APDN Stock Five Years Ago, You'd Be Sitting On A 92% Loss, Today

2019-04-29 09:15:00 | LineaRx Achieves Higher Expression and Survival Rates in Human T Cells Transfected Non-Virally with Linear DNA

2019-04-24 13:00:00 | Applied DNA Receives Initial $1 Million Payment from TheraCann International

2019-04-22 14:09:00 | Applied DNA and GHCL Launch “REKOOP” Verified by the CertainT Platform on Amazon.com on Earth Day

2019-04-12 03:00:00 | Applied DNA Signs Memorandum of Understanding with Process Chemicals Leader Stahl to Bring CertainT® Platform to Manufacturing Supply Chains

2019-04-08 08:00:00 | Applied DNA Subsidiary LineaRx Achieves Biotech Industry First with Anti-CD19 Expression in Human CAR T Cells via Proprietary Non-Viral, Plasmid-Free Platform

2019-04-03 14:05:00 | Applied DNA’s Platform Empowers President Trump’s Anti-Counterfeiting Memorandum Signed Today to Protect American Consumers and Industries

2019-04-02 08:45:00 | Loftex Sets New Standard in Sustainability Utilizing CertainT

2019-03-29 11:17:50 | Biotech Stock Applied DNA Sciences Jumps 50% On Cannabis Deal

2019-03-29 05:30:00 | Applied DNA Announces Exclusive Cannabis Licensing and Cooperation Agreement with Theracann International

2019-03-01 10:35:22 | Applied DNA Sciences, Inc. NASDAQ:APDN Insiders Increased Their Holdings

2019-03-01 05:00:00 | Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates

2019-02-12 05:00:00 | Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT® Platform in Legal Cannabis and Hemp

2019-02-08 22:11:50 | Edited Transcript of APDN earnings conference call or presentation 7-Feb-19 9:30pm GMT

2019-02-07 18:02:33 | Applied DNA Sciences: Fiscal 1Q Earnings Snapshot

2019-02-07 16:05:00 | Applied DNA Reports Fiscal First Quarter 2019 Financial Results

2019-02-06 15:46:00 | Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis iCAN

2019-01-31 05:00:00 | Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET

2019-01-29 05:00:00 | Applied DNA Appoints Stephen Birkhold to the Strategic Advisory Board

2019-01-28 05:00:00 | Applied DNA Signs MOU with Tex-Ray Industrial to Introduce CertainT® Authentication Platform to Global Textile Brands

2019-01-24 05:00:00 | Applied DNA Signs Memorandum of Understanding with Sun Chemical Supply Company to Bring CertainT® Authentication Platform to Textile Manufacturers in Asia

2018-12-27 16:05:00 | Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants

2018-12-21 08:30:00 | Applied DNA Announces Pricing of $2.75 Million Offering of Common Stock and Warrants